Acute lymphoblastic leukemia
Conditions
Interventions
Experimental:General clinical treatment
Sponsors
Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Science
Eligibility
Sex/Gender
All
Age
15 Years to 59 Years
Inclusion criteria
Inclusion criteria: The patients 1. to be firstly diagnosed as the acute lymphoblastic leukaemia; 2. to be aged 15 years to 60 years, man and women; 3. ECOG scores 0-2; 4. to be loss than the normal value 1.5 folders compared to same ages in last two weeks; AST and ALT <=5 folders of normal value compared to same ages; blood creatine concentration less than 2 folders of normal value of same ages; cardiac enzymes less than 2 folders of normal value of same ages; 5. to be negative in anti-HIV test; 6. to be signed the informed consent by the patients themselves, or their curators or family member.
Exclusion criteria
Exclusion criteria: We will exclude patients 1. to be combined with any severe complications, i.e. lung infection, uncontrolled diabetes; 2. to be combined with organ dysfunction or disease; 3. pregnancy; 4. to be acute transformed of chronic myelocytic leukemia; 5. to be identified who do not suitable for the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of survival without disease;Survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Remission rate; | — |
Countries
China
Contacts
Public ContactLugui Qiu
Outcome results
None listed